Literature DB >> 3091683

Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.

P F Gores, D E Sutherland, J L Platt, F H Bach.   

Abstract

Culture of pancreatic islets reduces their immunogenicity and results in prolonged graft survival after allotransplantation. The mechanism by which immunogenicity is reduced by culture is not known, but it has been suggested that prolonged graft survival is the result of the depletion of Ia+ cells from the graft. We studied the effect of eliminating Ia+ cells from islets before allotransplantation. Freshly isolated islets were incubated with anti-Ia serum plus complement or with monoclonal antibody to IAk plus complement or were left untreated before transplantation beneath the renal capsule of diabetic recipients. Incubation with anti-Ia serum plus complement eliminated intra-islet IA+ cells as demonstrated by indirect immunofluorescence staining. Incubation with monoclonal antibody to IAk plus complement significantly reduced but did not eliminate IA+ cells. Neither pretreatment regimen influenced survival of islet allografts placed beneath the renal capsule. However, untreated islets injected into the portal circulation were rejected in a low percentage of cases. We conclude that decreased immunogenicity observed after culture is not due solely to the depletion of Ia+ cells and that the site of engraftment has an important impact on graft survival.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091683

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.

Authors:  C P Larsen; J M Austyn; P J Morris
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

Review 2.  Transplantation in diabetes: a cell biological problem.

Authors:  F Purrello; D Pipeleers
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

3.  Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.

Authors:  R G Bretzel; B K Flesch; G Brennenstuhl; I Greiner; B J Hering; M Woehrle; K Federlin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.